Europe Orders Full Safety Probe of Cox-2 Drugs
433569
The European Commission has ordered a full-scale probe into the safety of five remaining Cox-2 arthritis drugs, following last month&#39;s
238122
The Food and Drug Administration yesterday called for an evaluation of all prevention studies involving two controversial painkillers - Celebrex and Bextra - to ensure adequate protection for participants who use the pills.
272490
The US Food and Drug Administration is recommending physicians limit prescriptions for popular painkillers known as Cox-2 inhibitors after recent studies suggested they may increase the risk of heart attacks and strokes.
210517
The European Medicines Agency is to review all drugs in the same class as Vioxx after US pharmaceutical giant Merck withdrew the arthritis drug.
573622
FRIDAY, Oct. 8 (HealthDayNews) -- A week after drug giant Merck & Co. withdrew its arthritis drug Vioxx from the market, doubts are being raised about the safety of the two other approved medications in this class, Bextra and Celebrex.
114059
Pfizer Inc. said on Monday it plans to  sponsor a major clinical study to further assess the  cardiovascular safety of its arthritis drug Celebrex following  the withdrawal of Merck & Co.'s Vioxx, a drug in the same  class.
466531
New evidence shows all popular arthritis painkillers known as COX-2 inhibitors may put users at greater risk of heart attacks and strokes, the latest addition to the recent crop of safety concerns for the drugs.
291840
In the first epidemiological study designed and executed specifically to determine the heart-attack risk associated with COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex), researchers at the University of Pennsylvania School of Medicine found a
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
201230
Washington - The health risks found in pain-relieving drugs known as COX-2 inhibitors, such as Vioxx, underscore the need for health authorities to test drugs already on the market, a top United States (US) cardiologist has warned.
401491
European regulators are carrying out a safety review following fears that five arthritis drugs could increase the risk of strokes and heart attacks.
752190
Far-reaching safety rules on tens of thousands of chemicals used in everyday items from car seats to face cream took effect in the European Union on Friday, obliging firms to show their products comply.
115886
Swiss drugmaker Novartis AG has informed doctors in Europe of new restrictions on prescribing lumiracoxib, its COX-2 inhibitor sold under the trade name Prexige, including regular liver monitoring, Britain's drug regulator said.
518059
Scientists and European regulators are now questioning the safety of other pain relievers like Vioxx, saying they also might raise the risk of heart attack and stroke.
160003
The safety of herbal medicines, which are widely used on the basis of scant scientific evidence, is to be investigated by a new panel of European experts.
328835
Dr David Graham, associate director for science in the Office of Drug Safety at FDA, alleged in a &quot;series of testy e-mail exchanges&quot; that agency officials &quot;delayed and demeaned&quot; the results of a study he conducted that found Vioxx -- a COX-2 inhibitor